Literature DB >> 2505368

Association of class I, II, and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study.

K Hartung1, A Fontana, M Klar, H Krippner, K Jörgens, B Lang, H H Peter, W J Pichler, D Schendel, M Robin-Winn.   

Abstract

Class I, II, and III MHC gene products were examined in 248 Central European SLE patients. The previously reported association with HLA-A1, -B8 and -DR3, and C4AQ0 alleles was confirmed. The frequency of HLA-DR2 was also slightly elevated in SLE patients, while no increase in C4BQ0 alleles was observed. Additional findings were a significantly increased frequency of HLA-B13 and a significant decrease of HLA-B44.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2505368     DOI： 10.1007/bf00270284

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  49 in total

1.  B-lymphocyte alloantigens associated with systemic lupus erythematosus.

Authors:  J L Reinertsen; J H Klippel; A H Johnson; A D Steinberg; J L Decker; D L Mann
Journal:  N Engl J Med       Date:  1978-09-07       Impact factor: 91.245

2.  The distribution of HL-A histocompatibility factors and genes in patients with systemic lupus erythematosus.

Authors:  H Waters; P Konrad; R L Walford
Journal:  Tissue Antigens       Date:  1971

3.  Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus.

Authors:  J M Ahearn; T T Provost; C A Dorsch; M B Stevens; W B Bias; F C Arnett
Journal:  Arthritis Rheum       Date:  1982-09

4.  [Association of HLA-antigens with systemic lupus erythematodes and its symptoms (author's transl)].

Authors:  H J Lakomek; C Specker; B M Kuntz; G Goerz
Journal:  Dtsch Med Wochenschr       Date:  1982-05-21       Impact factor: 0.628

5.  Letter: HL-A antigens and M.I.C. responsiveness in systemic lupus erythematosus.

Authors:  N Suciu-Foca; J Buda; P Almojera; K Reemtsma
Journal:  Lancet       Date:  1974-09-21       Impact factor: 79.321

6.  Prevalence of HLA-DRw2 not increased in systemic lupus erythematosus.

Authors:  O Scherak; J S Smolen; W R Mayr
Journal:  N Engl J Med       Date:  1979-09-13       Impact factor: 91.245

7.  Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets.

Authors:  M C Hochberg; R E Boyd; J M Ahearn; F C Arnett; W B Bias; T T Provost; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1985-09       Impact factor: 1.889

8.  MHC-linked class III genes. Analysis of C4 gene frequencies, complotypes and associations with distinct HLA haplotypes in German Caucasians.

Authors:  D J Schendel; G J O'Neill; R Wank
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

9.  Anti-C3b-receptor (CR1) antibodies in patients with systemic lupus erythematosus.

Authors:  J M Cook; M D Kazatchkine; P Bourgeois; F Mignon; J P Mery; M F Kahn
Journal:  Clin Immunol Immunopathol       Date:  1986-01

10.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05
View more
  12 in total

Review 1.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  Increased HLA A1 and diminished HLA A3 in lymphocytic colitis compared to controls and patients with collagenous colitis.

Authors:  F M Giardiello; A J Lazenby; J H Yardley; W B Bias; J Johnson; R G Alianiello; M S Bedine; T M Bayless
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

3.  The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group.

Authors:  K Hartung; H Ehrfeld; H J Lakomek; R Coldewey; B Lang; F Krapf; R Müller; D Schendel; H Deicher; H P Seelig
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

4.  Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE).

Authors:  M A Dragon-Durey; N Rougier; J P Clauvel; S Caillat-Zucman; P Remy; L Guillevin; F Liote; J Blouin; F Ariey; B U Lambert; M D Kazatchkine; L Weiss
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

5.  DR2 haplotypes (DRB1, DQA1, DQB1) associated with systemic lupus erythematosus.

Authors:  M P Bettinotti; K Hartung; H R Deicher; E Keller; S Mikschl; E Albert
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematosus. SLE Study Group members.

Authors:  Z Yao; A Kimura; K Hartung; P J Haas; A Volgger; G Brünnler; J Bönisch; E D Albert
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

7.  Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus.

Authors:  E Röther; B Lang; R Coldewey; K Hartung; H H Peter
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

8.  Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.

Authors:  K Hartung; M P Baur; R Coldewey; M Fricke; J R Kalden; H J Lakomek; H H Peter; D Schendel; P M Schneider; S A Seuchter
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes.

Authors:  M P Bettinotti; K Hartung; H Deicher; G Messer; E Keller; E H Weiss; E D Albert
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

10.  MHC associations of autoantibodies against recombinant Ro and La proteins in systemic lupus erythematosus. Results of a multicenter study. SLE Study Group.

Authors:  H Ehrfeld; K Hartung; M Renz; R Coldewey; H Deicher; M Fricke; J R Kalden; J Lakomek; H H Peter; D Schendel
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.